Judi Manola - Concepedia

Author

Judi Manola

Dana-Farber Cancer Institute

Also Known As

J MANOLA, J Manola, J. Manola, Judi Manola

Publications

735

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Brigham and Women's Hospital Harvard University

About

Judi Manola is an author at Dana-Farber Cancer Institute specializing in radiation oncology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	218
2	Health Sciences	2	2	161
3	Pathology	2	2	161
4	Gastroenterology	1	1	133
5	Pharmacology	1	1	28

Judi Manola

Publications

695

Citations

H-Index

Page 1

	Year	Citations
No long-term increase in cardiac-related mortality after breast-conserving surgery and radiation therapy using modern techniques. Asa J. Nixon, Judi Manola, Rebecca Gelman, Journal of Clinical Oncology	1998	174
Clonal Evolution of Resistance to Imatinib in Patients with Metastatic Gastrointestinal Stromal Tumors Jayesh Desai, Sridhar Shankar, Michael C. Heinrich, Clinical Cancer Research GastroenterologyPathologyResistant Clonal NoduleTumor BiologyOncology	2007	133
A practical method to achieve prostate gland immobilization and target verification for daily treatment Anthony V. D’Amico, Judi Manola, Marian Loffredo, International Journal of Radiation OncologyBiologyPhysics UrologyProstate Gland ImmobilizationDaily TreatmentTarget VerificationBenign Prostatic Hyperplasia	2001	95
The Effect of Androgen Deprivation Therapy on Fasting Serum Lipid and Glucose Parameters Jennifer Yannucci, Judi Manola, Marc B. Garnick, The Journal of Urology	2006	84
Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer. Elizabeth Chabner, Asa J. Nixon, Rebecca Gelman, Journal of Clinical Oncology	1998	74
Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy Michael D Thomas, Robert A. Cormack, Clare M. Tempany, International Journal of Radiation OncologyBiologyPhysics Acute Urinary RetentionUrologyMagnetic-resonance-guided Prostate BrachytherapyBenign Prostatic HyperplasiaUrogynecology	2000	57
Retroperitoneal Lymphadenectomy for High Risk, Nonmetastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG-ACRIN 2805) Adjuvant Trial Benjamin T. Ristau, Judi Manola, Naomi B. Haas, The Journal of Urology	2017	50
A multicenter phase II study of regorafenib in patients (pts) with advanced gastrointestinal stromal tumor (GIST), after therapy with imatinib (IM) and sunitinib (SU). Suzanne George, Margaret von Mehren, Michael C. Heinrich, Journal of Clinical Oncology OncologyGastrointestinal OncologyEligible PtsMedicineHand-foot Skin Reaction	2011	28

Page 1